Cadila pharmaceutical is the company which manufacturers Hydroxycloroquine medicines. This drug is in great demand throughout the world. More than 30 countries have requested India to supply Hydroxycloroquine medicine including US and Malaysia. India produces worlds 70 percentage of this Hydroxycloroquine medicine which is proved to be good in treatment of corona virus. This medicine is usually used for treatment of maleria patients. But now it is proved to be working well for corona infected patients and results are good. Indian government has agreed to supply Hydroxycloroquine medicine to USA but on some conditions that ban of Indian pharmaceutical companies to assess US market should be removed. Earlier USA has had banned Indian pharmaceutical companies to sell in USA. But now as USA is in badly need of this medicine so it has requested India government to supply this medicine. Cadila and ipca are the two major companies who manufacture this madicine in large quantities. As the demand for this has increased dramatically, it is expected that shares of these companies may also rise dramatically in stock market.
